• 1
    Rigel D, Friedman R, Kopf A. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1.5. J Am Acad Dermatol 1996; 35: 101213.
  • 2
    de Vries E, Poll-Franse L, Louwman W et al. Predictions of skin cancer incidence in The Netherlands up to 2015. Br J Dermatol 2005; 152: 4818.
  • 3
    Bernard P, Dupuy A, Sasco A et al. Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional survey. Dermatology 2008; 216: 1949.
  • 4
    Flohil S, de Vries E, Neumann H et al. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011; 91: 2430.
  • 5
    de Vries E, van der Rhee H, Coebergh J. Trends, causes, treatment and consequences of skin cancer epidemic in the Netherlands and Europe (in Dutch). Ned Tijdschr Geneeskd 2006; 150: 110815.
  • 6
    Kiiski V, de Vries E, Flohil S et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010; 146: 84855.
  • 7
    van der Geer S, Reijers H, van Tuijl H et al. Need for a new skin cancer management strategy. Arch Dermatol 2010; 146: 3326.
  • 8
    Trakatelli M, Ulrich C, del Marmol V et al. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007; 156 (Suppl. 3): 17.
  • 9
    Lamberg A, Cronin-Fenton D, Olesen A. Registration in the Danish Regional Nonmelanoma Skin cancer Dermatology Database: completeness of registration and accuracy of key variables. Clin Epidemiol 2010; 2: 12336.
  • 10
    Mans R, Schonenberg H, Leonardi G et al. Process mining techniques: an application to stroke care. In: Proceedings of the 21st International Congress of the European Federation for Medical Informatics (MIE 2008). Studies in Health Technology and Informatics, Vol. 136 (Andersen SK, ed). The Netherlands: IOS Press, 2008; 5738.